FLT3 and acute lymphoblastic leukemia: Recently, FLT3 mutations were reported in 4/57 (7%) of dogs with cytologically and immunophenotypically confirmed ALL [19], suggesting that this important mechanism of leukemia development and/or progression might be another instance of cross-species conservation of pathogenic mechanism.